Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis

OBJECTIVE: Immunosuppression is cornerstone treatment of antineutrophil cytoplasmic antibody associated vasculitis (AAV) but is later complicated by infection, cancer, cardiovascular and chronic kidney disease. Caveolin-1 is an essential structural protein for small cell membrane invaginations known...

Description complète

Détails bibliographiques
Auteurs principaux:	Chand, S, Holle, J, Hilhorst, M, Simmonds, M, Smith, S, Kamesh, L, Hewins, P, McKnight, A, Maxwell, A, Cohen Tervaert, J, Wieczorek, S, Harper, L, Borrows, R
Format:	Journal article
Langue:	English
Publié:	Public Library of Science 2013

Documents similaires

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
par: Mukhtyar, C, et autres
Publié: (2006)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
par: Morishita, K, et autres
Publié: (2017)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
par: Mukhtyar, C, et autres
Publié: (2008)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
par: Flossmann, O, et autres
Publié: (2006)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
par: Talks, S, et autres
Publié: (1994)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
par: De Groot, K, et autres
Publié: (2005)

Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure.
par: Moore, J, et autres
Publié: (2010)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
par: Mukhtyar, C, et autres
Publié: (2008)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
par: Robson, J, et autres
Publié: (2017)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
par: Walsh, M, et autres
Publié: (2011)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
par: de Groot, K, et autres
Publié: (2009)

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
par: Jayne, DR, et autres
Publié: (1997)

Goodpasture's syndrome with antineutrophil cytoplasmic antibodies
par: Losada, E, et autres
Publié: (1993)

Antineutrophil cytoplasmic antibodies in autoimmune hepatitis.
par: Bansi, D, et autres
Publié: (1995)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
par: Robson, J, et autres
Publié: (2013)

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
par: Harper, L, et autres
Publié: (2004)

Mannose-binding lectin gene polymorphisms in a cohort study of ANCA-associated small vessel vasculitis.
par: Kamesh, L, et autres
Publié: (2007)

Characterisation of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis
par: Cameron, B, et autres
Publié: (1998)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
par: Bansi, D, et autres
Publié: (1995)

Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
par: Bansi, D, et autres
Publié: (1996)

CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis.
par: Kamesh, L, et autres
Publié: (2009)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
par: Hellmich, B, et autres
Publié: (2007)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
par: Bansi, D, et autres
Publié: (1995)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
par: Guerry, M, et autres
Publié: (2012)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
par: Basu, N, et autres
Publié: (2014)

Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
par: Bansi, D, et autres
Publié: (1996)

Detection of antineutrophil cytoplasmic antibody in primary sclerosing cholangitis: Comparison of the alkaline phosphatase and immunofluorescent techniques.
par: Bansi, D, et autres
Publié: (1996)

DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
par: Bansi, D, et autres
Publié: (1995)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES ARE ABSENT IN UNAFFECTED RELATIVES OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
par: Bansi, D, et autres
Publié: (1995)

Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
par: Bansi, D, et autres
Publié: (1996)

Association of Caveolin-1 Gene Polymorphism With Kidney Transplant Fibrosis and Allograft Failure
par: Moore, J
Publié: (2010)

Characterization of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis (PSC) ulcerative colitis (UC).
par: Cameron, B, et autres
Publié: (1998)

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
par: Bansi, D, et autres
Publié: (1997)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TITER BUT NOT IGG SUBCLASS DISTINGUISHES BETWEEN PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS
par: Bans, D, et autres
Publié: (1995)

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
par: Bansi, D, et autres
Publié: (1996)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
par: Robson, J, et autres
Publié: (2017)

Caveolin-1 and lipid rafts in confluent BeWo trophoblasts: evidence for Rock-1 association with caveolin-1.
par: Rashid-Doubell, F, et autres
Publié: (2007)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
par: Luqmani, R, et autres
Publié: (2017)

Regulation of trophoblast differentiation and fusion by Caveolin-1
par: Collent, G, et autres
Publié: (2008)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
par: Merkel, P, et autres
Publié: (2009)